Polyomavirus allograft nephropathy

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy
Status:
Completed
Last Changed:
Mar 28, 2017
First Changed:
Sep 12, 2005
Disease(s):
Polyomavirus Infections
Intervention(s):
Ciclosporin and Mycophenolate-mofetilTacrolimus and Mycophenolate-mofetilTacrolimus and Mycophenolate-mofetil with change from Mycophenolate-mofetil to Everolimus
Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
Status:
Completed
Last Changed:
Nov 29, 2016
First Changed:
May 3, 2011
Disease(s):
Acute Graft Rejection
Intervention(s):
cyclosporine or tacrolimus

Connect. Empower. Inspire.